The postprandial actions of GLP-1 receptor agonists: The missing link for cardiovascular and kidney protection in type 2 diabetes
出版年份 2023 全文链接
标题
The postprandial actions of GLP-1 receptor agonists: The missing link for cardiovascular and kidney protection in type 2 diabetes
作者
关键词
-
出版物
Cell Metabolism
Volume 35, Issue 2, Pages 253-273
出版商
Elsevier BV
发表日期
2023-02-07
DOI
10.1016/j.cmet.2023.01.004
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Gut Microbial Signatures for Glycemic Responses of GLP-1 Receptor Agonists in Type 2 Diabetic Patients: A Pilot Study
- (2022) Chih-Yiu Tsai et al. Frontiers in Endocrinology
- Management of type 2 diabetes with the dual GIP/GLP-1 receptor agonist tirzepatide: a systematic review and meta-analysis
- (2022) Thomas Karagiannis et al. DIABETOLOGIA
- GLP-1 and GIP receptor signaling in beta cells – A review of receptor interactions and co-stimulation
- (2022) Ashok Mayendraraj et al. PEPTIDES
- Brain Activation in Response to Low-Calorie Food Pictures: An Explorative Analysis of a Randomized Trial With Dapagliflozin and Exenatide
- (2022) Charlotte C. van Ruiten et al. Frontiers in Endocrinology
- The Sensory Mechanisms of Nutrient-Induced GLP-1 Secretion
- (2022) Anna Pii Hjørne et al. Metabolites
- A single, high-fat meal adversely affects postprandial endothelial function: a systematic review and meta-analysis
- (2022) Juanita J Fewkes et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Revisiting ‘intensive’ blood glucose control: A causal directed acyclic graph‐guided systematic review of randomized controlled trials
- (2022) Chi‐Jung Huang et al. DIABETES OBESITY & METABOLISM
- Intestinal lipid absorption and transport in type 2 diabetes
- (2022) Bruno Vergès DIABETOLOGIA
- Glucagon-like Peptide-1 Receptor-based Therapeutics for Metabolic Liver Disease
- (2022) Julian M Yabut et al. ENDOCRINE REVIEWS
- Suppression of angiotensin II-activated NOX4/NADPH oxidase and mitochondrial dysfunction by preserving glucagon-like peptide-1 attenuates myocardial fibrosis and hypertension
- (2022) Trenton E. Banks et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- The anti-inflammatory and immunological properties of GLP-1 Receptor Agonists
- (2022) Giulia Bendotti et al. PHARMACOLOGICAL RESEARCH
- Efficacy of subcutaneous semaglutide compared to placebo for weight loss in obese, non-diabetic adults: a systematic review & meta-analysis
- (2022) Naazneen Arastu et al. International Journal of Clinical Pharmacy
- Obesity-Related Chronic Kidney Disease: Principal Mechanisms and New Approaches in Nutritional Management
- (2022) Alessandra Stasi et al. Frontiers in Nutrition
- Glucagon and other proglucagon-derived peptides in the pathogenesis of obesity
- (2022) Jens Juul Holst Frontiers in Nutrition
- Glucagon-Like Peptide-1 Receptor Regulates Thromboxane-Induced Human Platelet Activation
- (2022) Katherine N. Cahill et al. JACC-Basic to Translational Science
- Managing thrombotic risk in patients with diabetes
- (2022) A. John Camm et al. Cardiovascular Diabetology
- Impact of semaglutide on high-sensitivity C-reactive protein: exploratory patient-level analyses of SUSTAIN and PIONEER randomized clinical trials
- (2022) Ofri Mosenzon et al. Cardiovascular Diabetology
- The role of gut-derived oxidized lipids and bacterial lipopolysaccharide in systemic inflammation and atherosclerosis
- (2022) Huan Wang et al. CURRENT OPINION IN LIPIDOLOGY
- Effect of glucagon-like peptide 1 receptor agonists on the renal protection in patients with type 2 diabetes: A systematic review and meta-analysis
- (2022) Xiang Li et al. DIABETES & METABOLISM
- Tirzepatide suppresses palatable food intake by selectively reducing preference for fat in rodents
- (2022) Caroline E. Geisler et al. DIABETES OBESITY & METABOLISM
- Activation of arcuate nucleus glucagon-like peptide-1 receptor-expressing neurons suppresses food intake
- (2022) Ishnoor Singh et al. Cell and Bioscience
- Effects of tirzepatide versus insulin glargine on kidney outcomes in type 2 diabetes in the SURPASS-4 trial: post-hoc analysis of an open-label, randomised, phase 3 trial
- (2022) Hiddo J L Heerspink et al. Lancet Diabetes & Endocrinology
- GLP-1 attenuates intestinal fat absorption and chylomicron production via vagal afferent nerves originating in the portal vein
- (2022) Simon Hoffman et al. Molecular Metabolism
- Postprandial changes of oxidative stress biomarkers in healthy individuals
- (2022) Fengyi Huang et al. Frontiers in Nutrition
- Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk
- (2022) Aruna Das Pradhan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials
- (2021) Suetonia C Palmer et al. BMJ-British Medical Journal
- Dietary fat intakes and cardiovascular disease risk in adults with type 2 diabetes: a systematic review and meta-analysis
- (2021) Ursula Schwab et al. EUROPEAN JOURNAL OF NUTRITION
- GLP-1 (Glucagon-Like Peptide-1) Is Physiologically Relevant for Chylomicron Secretion Beyond Its Known Pharmacological Role
- (2021) Avital Nahmias et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- The effect of glucagon-like peptide-1 receptor agonists on 24-hour ambulatory blood pressure
- (2021) Dimitrios Patoulias et al. BLOOD PRESSURE MONITORING
- Glucagon‐like peptide‐1 receptor agonists improve biomarkers of inflammation and oxidative stress: A systematic review and meta‐analysis of randomised controlled trials
- (2021) Jonathan J. H. Bray et al. DIABETES OBESITY & METABOLISM
- Potential kidney protection with liraglutide and semaglutide – exploratory mediation analysis
- (2021) Johannes F. E. Mann et al. DIABETES OBESITY & METABOLISM
- Effect of exenatide twice daily and dapagliflozin, alone and in combination, on markers of kidney function in obese patients with type 2 diabetes: A prespecified secondary analysis of a randomized controlled clinical trial
- (2021) Charlotte C. van Ruiten et al. DIABETES OBESITY & METABOLISM
- Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity
- (2021) Domenica Rubino et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Targeting inflammation in atherosclerosis — from experimental insights to the clinic
- (2021) Oliver Soehnlein et al. NATURE REVIEWS DRUG DISCOVERY
- Liraglutide-induced structural modulation of the gut microbiota in patients with type 2 diabetes mellitus
- (2021) Junjie Shang et al. PeerJ
- Effect of ingesting a meal and orthostasis on the regulation of splanchnic and systemic hemodynamics and the responsiveness of cardiovascular α1-adrenoceptors
- (2021) Farid Zreik et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Brain GLP‐1 and the regulation of food intake: GLP‐1 action in the brain and its implications for GLP‐1 receptor agonists in obesity treatment
- (2021) Stefan Trapp et al. BRITISH JOURNAL OF PHARMACOLOGY
- Reappraising the role of the vagus nerve in GLP‐1‐mediated regulation of eating
- (2021) Daniel I. Brierley et al. BRITISH JOURNAL OF PHARMACOLOGY
- Hypofibrinolysis in type 2 diabetes and its clinical implications: from mechanisms to pharmacological modulation
- (2021) Agata Hanna Bryk-Wiązania et al. Cardiovascular Diabetology
- Postprandial superior mesenteric artery blood flow is related to changes in peripheral pulse wave harmonics and heart rate: implications for wearable technology?
- (2021) Eamon Abdullah et al. JOURNAL OF APPLIED PHYSIOLOGY
- Cardiovascular and Renal Outcomes with Efpeglenatide in Type 2 Diabetes
- (2021) Hertzel C. Gerstein et al. NEW ENGLAND JOURNAL OF MEDICINE
- Potential for Gut Peptide-Based Therapy in Postprandial Hypotension
- (2021) Malcolm J. Borg et al. Nutrients
- Metabolic endotoxemia is dictated by the type of lipopolysaccharide
- (2021) Fernando F. Anhê et al. Cell Reports
- Gastrointestinal Distension by Pectin-Containing Carbonated Solution Suppresses Food Intake and Enhances Glucose Tolerance via GLP-1 Secretion and Vagal Afferent Activation
- (2021) Kento Ohbayashi et al. Frontiers in Endocrinology
- What Is an L-Cell and How Do We Study the Secretory Mechanisms of the L-Cell?
- (2021) Rune E. Kuhre et al. Frontiers in Endocrinology
- Exploring potential mediators of the cardiovascular benefit of dulaglutide in type 2 diabetes patients in REWIND
- (2021) Manige Konig et al. Cardiovascular Diabetology
- Effect of the Glucagon-Like Peptide-1 Receptor Agonists Semaglutide and Liraglutide on Kidney Outcomes in Patients With Type 2 Diabetes: Pooled Analysis of SUSTAIN 6 and LEADER
- (2021) Ahmed M. Shaman et al. CIRCULATION
- Association between weight change and incidence of cardiovascular disease events and mortality among adults with type 2 diabetes: a systematic review of observational studies and behavioural intervention trials
- (2021) Jean Strelitz et al. DIABETOLOGIA
- Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials
- (2021) Naveed Sattar et al. Lancet Diabetes & Endocrinology
- Meta-Analysis of Randomized Controlled Trials Evaluating the Effect of Dual Glucose-Dependent Insulinotropic Polypeptide and Glucagon-Like Peptide-1 Receptor Agonists on Blood Pressure Levels in Patients With Type 2 Diabetes Mellitus
- (2021) Dimitrios Patoulias et al. AMERICAN JOURNAL OF CARDIOLOGY
- GLP-1 physiology informs the pharmacotherapy of obesity
- (2021) Daniel J. Drucker Molecular Metabolism
- Native, Intact Glucagon-Like Peptide 1 Is a Natural Suppressor of Thrombus Growth Under Physiological Flow Conditions
- (2020) Marieke Sternkopf et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Cardioprotective GLP-1 metabolite prevents ischemic cardiac injury by inhibiting mitochondrial trifunctional protein-α
- (2020) M. Ahsan Siraj et al. JOURNAL OF CLINICAL INVESTIGATION
- The effect of dulaglutide on stroke: an exploratory analysis of the REWIND trial
- (2020) Hertzel C Gerstein et al. Lancet Diabetes & Endocrinology
- Glucagon-like peptide-1 receptor agonists and the risk of cardiovascular events in diabetes patients surviving an acute myocardial infarction
- (2020) Marco Trevisan et al. European Heart Journal-Cardiovascular Pharmacotherapy
- Comparison of the effects of twice-daily exenatide and insulin on carotid intima-media thickness in type 2 diabetes mellitus patients: a 52-week randomized, open-label, controlled trial
- (2020) Jie Zhang et al. Cardiovascular Diabetology
- Exploring the Possible Impact of Unbalanced Open-Label Drop-In of Glucose-Lowering Medications on EXSCEL Outcomes
- (2020) M. Angelyn Bethel et al. CIRCULATION
- Cardiovascular Risk Reduction With Liraglutide: An Exploratory Mediation Analysis of the LEADER Trial
- (2020) John B. Buse et al. DIABETES CARE
- Glucose control: not just a bystander in GLP-1RA-mediated cardiovascular protection
- (2020) Irene Caruso et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- SELECT (Semaglutide effects on cardiovascular outcomes in people with overweight or obesity) rationale and design
- (2020) Donna H. Ryan et al. AMERICAN HEART JOURNAL
- Transient Intermittent Hyperglycemia Accelerates Atherosclerosis by Promoting Myelopoiesis
- (2020) Michelle C Flynn et al. CIRCULATION RESEARCH
- Remnant lipoproteins
- (2020) Carlos A. Aguilar Salinas et al. CURRENT OPINION IN LIPIDOLOGY
- Intestine-selective reduction of Gcg expression reveals the importance of the distal gut for GLP-1 secretion
- (2020) Brandon L. Panaro et al. Molecular Metabolism
- Tirzepatide is an imbalanced and biased dual GIP and GLP-1 receptor agonist
- (2020) Francis S. Willard et al. JCI Insight
- Strategies to Treat Obesity in Patients With CKD
- (2020) Kiran Chintam et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Legacy effect of intensive glucose control on major adverse cardiovascular outcome: Systematic review and meta-analyses of trials according to different scenarios
- (2020) Francesco Prattichizzo et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Dipeptidyl peptidase 4 inhibitors in the treatment of type 2 diabetes mellitus
- (2020) Carolyn F. Deacon Nature Reviews Endocrinology
- Dyslipidemia in Kidney Disorders: Perspectives on Mitochondria Homeostasis and Therapeutic Opportunities
- (2020) Pei-Hui Lin et al. Frontiers in Physiology
- GLP-1 receptor agonists in the treatment of type 2 diabetes – state-of-the-art
- (2020) Michael A. Nauck et al. Molecular Metabolism
- Postprandial Glucose Spikes, an Important Contributor to Cardiovascular Disease in Diabetes?
- (2020) Nordin M. J. Hanssen et al. Frontiers in Cardiovascular Medicine
- Antithrombotic Therapy for Atherosclerotic Cardiovascular Disease Risk Mitigation in Patients With Coronary Artery Disease and Diabetes Mellitus
- (2020) Davide Capodanno et al. CIRCULATION
- Revisiting the Complexity of GLP-1 Action from Sites of Synthesis to Receptor Activation
- (2020) Brent A McLean et al. ENDOCRINE REVIEWS
- Impact of glucagon response on early postprandial glucose excursions irrespective of residual β‐cell function in type 1 diabetes: A cross‐sectional study using a mixed meal tolerance test
- (2020) Ayako Ito et al. Journal of Diabetes Investigation
- Efficacy and Safety of Adjunctive Cilostazol to Clopidogrel‐Treated Diabetic Patients With Symptomatic Lower Extremity Artery Disease in the Prevention of Ischemic Vascular Events
- (2020) Kallirroi Kalantzi et al. Journal of the American Heart Association
- Exendin-4 induces a novel extended effect of ischemic tolerance via crosstalk with IGF-1R
- (2020) Huinan Zhang et al. BRAIN RESEARCH BULLETIN
- Comparative efficacy, safety, and cardiovascular outcomes with once-weekly subcutaneous semaglutide in the treatment of type 2 diabetes: Insights from the SUSTAIN 1–7 trials
- (2019) V. R Aroda et al. DIABETES & METABOLISM
- Effects of lixisenatide on postprandial blood pressure, gastric emptying and glycemia in health and type 2 diabetes
- (2019) Karen L. Jones et al. DIABETES OBESITY & METABOLISM
- Moderate weight change following diabetes diagnosis and 10 year incidence of cardiovascular disease and mortality
- (2019) Jean Strelitz et al. DIABETOLOGIA
- Protective effects of liraglutide on glomerular podocytes in obese mice by inhibiting the inflammatory factor TNF-α-mediated NF-κB and MAPK pathway
- (2019) Yongjian Ye et al. Obesity Research & Clinical Practice
- Residual inflammatory risk in coronary heart disease: incidence of elevated high-sensitive CRP in a real-world cohort
- (2019) Alexander Peikert et al. Clinical Research in Cardiology
- Effects of Blood Pressure Lowering on Clinical Outcomes According to Baseline Blood Pressure and Cardiovascular Risk in Patients With Type 2 Diabetes Mellitus
- (2019) Faisal Rahman et al. HYPERTENSION
- Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial
- (2019) Hertzel C Gerstein et al. LANCET
- Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
- (2019) Hertzel C Gerstein et al. LANCET
- Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
- (2019) Mansoor Husain et al. NEW ENGLAND JOURNAL OF MEDICINE
- Protective effects of glucagon‐like peptide‐1 on cardiac remodeling by inhibiting oxidative stress through mammalian target of rapamycin complex 1/p70 ribosomal protein S6 kinase pathway in diabetes mellitus
- (2019) Dongjuan Wang et al. Journal of Diabetes Investigation
- Distinct Neural Sites of GLP-1R Expression Mediate Physiological versus Pharmacological Control of Incretin Action
- (2019) Elodie M. Varin et al. Cell Reports
- Healthy Dietary Patterns and Incidence of CKD
- (2019) Katrina E. Bach et al. Clinical Journal of the American Society of Nephrology
- Initial injectable therapy in type 2 diabetes: Key considerations when choosing between glucagon-like peptide 1 receptor agonists and insulin
- (2019) Anastasia-Stefania Alexopoulos et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Glucagon-like peptide 1 (GLP-1)
- (2019) T.D. Müller et al. Molecular Metabolism
- Atherosclerosis
- (2019) Peter Libby et al. Nature Reviews Disease Primers
- Meta-analysis of the impact of alpha-glucosidase inhibitors on incident diabetes and cardiovascular outcomes
- (2019) Ruth L. Coleman et al. Cardiovascular Diabetology
- The oral glucose tolerance test-derived incremental glucose peak is associated with greater arterial stiffness and maladaptive arterial remodeling: The Maastricht Study
- (2019) Yuri D. Foreman et al. Cardiovascular Diabetology
- Postprandial Vascular Dysfunction Is Associated With Raised Blood Pressure and Adverse Left Ventricular Remodeling in Adolescent Adiposity
- (2019) Jakob A. Hauser et al. Circulation-Cardiovascular Imaging
- The rollercoaster history of using physiological and pharmacological properties of incretin hormones to develop diabetes medications with a convincing benefit-risk relationship
- (2019) Michael A. Nauck METABOLISM-CLINICAL AND EXPERIMENTAL
- Regulation of Gut Microbiota and Metabolic Endotoxemia with Dietary Factors
- (2019) Nobuo Fuke et al. Nutrients
- Simultaneous angiotensin receptor blockade and glucagon‐like peptide‐1 receptor activation ameliorate albuminuria in obese insulin‐resistant rats
- (2019) Ruben Rodriguez et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- MANAGEMENT OF ENDOCRINE DISEASE: Are all GLP-1 agonists equal in the treatment of type 2 diabetes?
- (2019) Michael A Nauck et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Glucagon-like peptide-1 increased the vascular relaxation response via AMPK/Akt signaling in diabetic mice aortas
- (2019) Kumiko Taguchi et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Human Postprandial Nutrient Metabolism and Low-Grade Inflammation: A Narrative Review
- (2019) Emma C.E. Meessen et al. Nutrients
- Diabetic Kidney Disease: Is There a Role for Glycemic Variability?
- (2018) Savitha Subramanian et al. Current Diabetes Reports
- Incretins and Lipid Metabolism
- (2018) Vasilis Tsimihodimos et al. CURRENT MEDICINAL CHEMISTRY
- Semaglutide induces weight loss in subjects with type 2 diabetes regardless of baseline BMI or gastrointestinal adverse events in the SUSTAIN 1 to 5 trials
- (2018) Bo Ahrén et al. DIABETES OBESITY & METABOLISM
- A single high-fat meal provokes pathological erythrocyte remodeling and increases myeloperoxidase levels: implications for acute coronary syndrome
- (2018) Tyler W Benson et al. LABORATORY INVESTIGATION
- Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial
- (2018) Paul M Ridker et al. LANCET
- GLP-1 receptor agonist ameliorates obesity-induced chronic kidney injury via restoring renal metabolism homeostasis
- (2018) Chengshi Wang et al. PLoS One
- Dulaglutide versus insulin glargine in patients with type 2 diabetes and moderate-to-severe chronic kidney disease (AWARD-7): a multicentre, open-label, randomised trial
- (2018) Katherine R Tuttle et al. Lancet Diabetes & Endocrinology
- The Origin and Understanding of the Incretin Concept
- (2018) Jens F. Rehfeld Frontiers in Endocrinology
- Glucagon-Like Peptide-1 and its Cleavage Products are Renoprotective in Murine Diabetic Nephropathy
- (2018) Moellmann Julia et al. DIABETES
- Liraglutide Treatment Reduces Endothelial Endoplasmic Reticulum Stress and Insulin Resistance in Patients With Diabetes Mellitus
- (2018) Rosa Bretón‐Romero et al. Journal of the American Heart Association
- Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
- (2018) Melanie J. Davies et al. DIABETOLOGIA
- Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
- (2018) Adrian F Hernandez et al. LANCET
- Thromboxane-Dependent Platelet Activation in Obese Subjects with Prediabetes or Early Type 2 Diabetes: Effects of Liraglutide- or Lifestyle Changes-Induced Weight Loss
- (2018) Paola Simeone et al. Nutrients
- The impact of liraglutide on the JAK-STAT pathway in diabetic kidney disease in db/db mice and in cultured endothelial cells
- (2018) Tali Zitman-Gal et al. Journal of Diabetes
- Lixisenatide and renal outcomes in patients with type 2 diabetes and acute coronary syndrome: an exploratory analysis of the ELIXA randomised, placebo-controlled trial
- (2018) Marcel H A Muskiet et al. Lancet Diabetes & Endocrinology
- Effects of Glucagon-Like Peptide-1 on Oxidative Stress and Nrf2 Signaling
- (2017) Yoon Oh et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Postprandial Hyperlipidemia and Remnant Lipoproteins
- (2017) Daisaku Masuda et al. Journal of Atherosclerosis and Thrombosis
- Treatment with GLP1 receptor agonists reduce serum CRP concentrations in patients with type 2 diabetes mellitus: A systematic review and meta-analysis of randomized controlled trials
- (2017) Mohsen Mazidi et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Metabolic endotoxemia and diabetes mellitus: A systematic review
- (2017) Júnia Maria Geraldo Gomes et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes
- (2017) Rury R. Holman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Liraglutide and Renal Outcomes in Type 2 Diabetes
- (2017) Johannes F.E. Mann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pancreatic α Cell-Derived Glucagon-Related Peptides Are Required for β Cell Adaptation and Glucose Homeostasis
- (2017) Shuyang Traub et al. Cell Reports
- Safety and Efficacy of Incretin-Based Therapies in Patients With Type 2 Diabetes Mellitus and CKD: A Systematic Review and Meta-analysis
- (2016) Patricia M. Howse et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Comprehensive assessment of the global and regional vascular responses to food ingestion in humans using novel rapid MRI
- (2016) Jakob A. Hauser et al. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
- Liraglutide improves metabolic parameters and carotid intima-media thickness in diabetic patients with the metabolic syndrome: an 18-month prospective study
- (2016) Manfredi Rizzo et al. Cardiovascular Diabetology
- Glucagon and heart in type 2 diabetes: new perspectives
- (2016) Antonio Ceriello et al. Cardiovascular Diabetology
- Glucagon-Like Peptide 1 Receptor Activation Attenuates Platelet Aggregation and Thrombosis
- (2016) Alison Cameron-Vendrig et al. DIABETES
- Acute renal haemodynamic effects of glucagon-like peptide-1 receptor agonist exenatide in healthy overweight men
- (2016) M. H. A. Muskiet et al. DIABETES OBESITY & METABOLISM
- Short-term effects of liraglutide on kidney function and vasoactive hormones in type 2 diabetes: a randomized clinical trial
- (2016) J. Skov et al. DIABETES OBESITY & METABOLISM
- Acute renal effects of the GLP-1 receptor agonist exenatide in overweight type 2 diabetes patients: a randomised, double-blind, placebo-controlled trial
- (2016) Lennart Tonneijck et al. DIABETOLOGIA
- Neuroprotective Effects of rhGLP-1 in Diabetic Rats with Cerebral Ischemia/Reperfusion Injury
- (2016) Daoli Jiang et al. DRUG DEVELOPMENT RESEARCH
- Differential effects of GLP-1 receptor agonist on foam cell formation in monocytes between non-obese and obese subjects
- (2016) Masashi Tanaka et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Central & peripheral glucagon-like peptide-1 receptor signaling differentially regulate addictive behaviors
- (2016) Sunil Sirohi et al. PHYSIOLOGY & BEHAVIOR
- Meal-induced platelet activation in diabetes mellitus type 1 or type 2 is related to postprandial insulin rather than glucose levels
- (2016) Galia Spectre et al. THROMBOSIS RESEARCH
- Postprandial Metabolism of Macronutrients and Cardiometabolic Risk: Recent Developments, Emerging Concepts, and Future Directions
- (2016) Miriam Jacome-Sosa et al. Advances in Nutrition
- Association of the magnitude of weight loss and changes in physical fitness with long-term cardiovascular disease outcomes in overweight or obese people with type 2 diabetes: a post-hoc analysis of the Look AHEAD randomised clinical trial
- (2016) Lancet Diabetes & Endocrinology
- Structural modulation of the gut microbiota and the relationship with body weight: compared evaluation of liraglutide and saxagliptin treatment
- (2016) Lin Wang et al. Scientific Reports
- In vivo evidence for chylomicrons as mediators of postprandial inflammation
- (2015) Marijke A. de Vries et al. ATHEROSCLEROSIS
- Effects of exenatide on postprandial vascular endothelial dysfunction in type 2 diabetes mellitus
- (2015) Keiichi Torimoto et al. Cardiovascular Diabetology
- Gut Peptides Are Novel Regulators of Intestinal Lipoprotein Secretion: Experimental and Pharmacological Manipulation of Lipoprotein Metabolism
- (2015) Changting Xiao et al. DIABETES
- Exenatide Protects Against Glucose- and Lipid-Induced Endothelial Dysfunction: Evidence for Direct Vasodilation Effect of GLP-1 Receptor Agonists in Humans
- (2015) Juraj Koska et al. DIABETES
- Effects of exogenous glucagon-like peptide-1 on blood pressure, heart rate, gastric emptying, mesenteric blood flow and glycaemic responses to oral glucose in older individuals with normal glucose tolerance or type 2 diabetes
- (2015) Laurence G. Trahair et al. DIABETOLOGIA
- Association of low GLP-1 with oxidative stress is related to cardiac disease and outcome in patients with type 2 diabetes mellitus: A pilot study
- (2015) Susana Ravassa et al. FREE RADICAL BIOLOGY AND MEDICINE
- Effect of glycemic state on postprandial hyperlipidemia and hyperinsulinemia in patients with coronary artery disease
- (2015) Akihiro Nakamura et al. HEART AND VESSELS
- Liraglutide Reduces Oxidative Stress And Restores Heme Oxygenase-1 and Ghrelin Levels in Patients with Type 2 Diabetes: A Prospective Pilot Study
- (2015) Manfredi Rizzo et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Glucagon-like peptide 1 receptor agonist (GLP-1 RA): long-term effect on kidney function in patients with type 2 diabetes
- (2015) Bernt Johan von Scholten et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Postprandial Hypotension Is Associated With More Rapid Gastric Emptying in Healthy Older Individuals
- (2015) Laurence G. Trahair et al. Journal of the American Medical Directors Association
- Postprandial Dysmetabolism and Oxidative Stress in Type 2 Diabetes: Pathogenetic Mechanisms and Therapeutic Strategies
- (2015) Barbara Sottero et al. MEDICINAL RESEARCH REVIEWS
- Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome
- (2015) Marc A. Pfeffer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Fast food increases postprandial cardiac workload in type 2 diabetes independent of pre-exercise: A pilot study
- (2015) Siri Marte Hollekim-Strand et al. Nutrition Journal
- Prognostic Value of Flow-Mediated Vasodilation in Brachial Artery and Fingertip Artery for Cardiovascular Events: A Systematic Review and Meta-Analysis
- (2015) Y. Matsuzawa et al. Journal of the American Heart Association
- Cardiovascular disease and mortality in patients with type 2 diabetes after bariatric surgery in Sweden: a nationwide, matched, observational cohort study
- (2015) Björn Eliasson et al. Lancet Diabetes & Endocrinology
- Diabetic kidney disease
- (2015) Merlin C. Thomas et al. Nature Reviews Disease Primers
- Intermittent High Glucose Implements Stress-Induced Senescence in Human Vascular Endothelial Cells: Role of Superoxide Production by NADPH Oxidase
- (2015) Morihiko Maeda et al. PLoS One
- Pronounced reduction of postprandial glucagon by lixisenatide: a meta-analysis of randomized clinical trials
- (2014) B. Ahrén et al. DIABETES OBESITY & METABOLISM
- Time course and mechanisms of the anti-hypertensive and renal effects of liraglutide treatment
- (2014) B. J. von Scholten et al. DIABETIC MEDICINE
- GLP-1 Receptor Localization in Monkey and Human Tissue: Novel Distribution Revealed With Extensively Validated Monoclonal Antibody
- (2014) Charles Pyke et al. ENDOCRINOLOGY
- Pathway-selective Insulin Resistance and Metabolic Disease: The Importance of Nutrient Flux
- (2014) Yolanda F. Otero et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Neuroprotective and anti-apoptotic effects of liraglutide in the rat brain following focal cerebral ischemia
- (2014) S. Briyal et al. NEUROSCIENCE
- Effect of a long-term behavioural weight loss intervention on nephropathy in overweight or obese adults with type 2 diabetes: a secondary analysis of the Look AHEAD randomised clinical trial
- (2014) Lancet Diabetes & Endocrinology
- Regulation of gastric emptying rate and its role in nutrient-induced GLP-1 secretion in rats after vertical sleeve gastrectomy
- (2013) Adam P. Chambers et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Glucagon-like peptide-1 (GLP-1) and its split products GLP-1(9-37) and GLP-1(28-37) stabilize atherosclerotic lesions in apoe−/− mice
- (2013) Mathias Burgmaier et al. ATHEROSCLEROSIS
- The GLP-1 receptor agonist liraglutide inhibits progression of vascular disease via effects on atherogenesis, plaque stability and endothelial function in an ApoE−/− mouse model
- (2013) Tracey Gaspari et al. Diabetes & Vascular Disease Research
- Exenatide-Induced Reduction in Energy Intake Is Associated With Increase in Hypothalamic Connectivity
- (2013) H. Schlogl et al. DIABETES CARE
- Glucagon-Like Peptide 1 Reduces Endothelial Dysfunction, Inflammation, and Oxidative Stress Induced by Both Hyperglycemia and Hypoglycemia in Type 1 Diabetes
- (2013) A. Ceriello et al. DIABETES CARE
- Positive association between high-sensitivity C-reactive protein and incidence of type 2 diabetes mellitus in Japanese workers: 6-year follow-up
- (2013) Chaochen Wang et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Glucagon-like peptide 1 analogue therapy directly modulates innate immune-mediated inflammation in individuals with type 2 diabetes mellitus
- (2013) Andrew E. Hogan et al. DIABETOLOGIA
- Early postprandial glucagon surge affects postprandial glucose levels in obese and non-obese patients with type 2 diabetes
- (2013) Junji Kozawa et al. ENDOCRINE JOURNAL
- The protective roles of GLP-1R signaling in diabetic nephropathy: possible mechanism and therapeutic potential
- (2013) Hiroki Fujita et al. KIDNEY INTERNATIONAL
- Real-time trafficking and signaling of the glucagon-like peptide-1 receptor
- (2013) Sarah Noerklit Roed et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes
- (2013) William B. White et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cardiovascular Effects of Intensive Lifestyle Intervention in Type 2 Diabetes
- (2013) NEW ENGLAND JOURNAL OF MEDICINE
- Prediction of Kidney-Related Outcomes in Patients With Type 2 Diabetes
- (2012) Meg J. Jardine et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Role of Intensive Glucose Control in Development of Renal End Points in Type 2 Diabetes Mellitus
- (2012) Steven G. Coca et al. ARCHIVES OF INTERNAL MEDICINE
- Glucagon-like peptide-1 (GLP-1) induces M2 polarization of human macrophages via STAT3 activation
- (2012) Daisuke Shiraishi et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- GLP-1 and cardioprotection: from bench to bedside
- (2012) S. Ravassa et al. CARDIOVASCULAR RESEARCH
- Sympathoinhibitory signals from the gut and obesity-related hypertension
- (2012) Daniela M. Sartor CLINICAL AUTONOMIC RESEARCH
- GLP-1 Receptor Activation Indirectly Reduces Hepatic Lipid Accumulation But Does Not Attenuate Development of Atherosclerosis in Diabetic MaleApoE−/−Mice
- (2012) Naim Panjwani et al. ENDOCRINOLOGY
- Effects of Fibrates in Kidney Disease
- (2012) Min Jun et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The ACCORD-Lipid study: implications for treatment of dyslipidemia in Type 2 diabetes mellitus
- (2011) Marshall Elam et al. Clinical Lipidology
- Glucagon-like peptide-1 receptor agonist ameliorates renal injury through its anti-inflammatory action without lowering blood glucose level in a rat model of type 1 diabetes
- (2011) R. Kodera et al. DIABETOLOGIA
- Glucagon-like Peptide-1 (GLP-1), Immediately Prior to Reperfusion, Decreases Neutrophil Activation and Reduces Myocardial Infarct Size in Rodents
- (2011) B. B. Dokken et al. HORMONE AND METABOLIC RESEARCH
- Significant Increase of Apolipoprotein B48 Levels by a Standard Test Meal in Type 2 Diabetic Patients with Nephropathy
- (2011) Takeshi Yamamoto et al. Journal of Atherosclerosis and Thrombosis
- Relationship between postprandial changes in cardiac left ventricular function, glucose and insulin concentrations, gastric emptying, and satiety in healthy subjects
- (2011) Joanna Hlebowicz et al. Nutrition Journal
- Lipoprotein-specific transport of circulating lipid peroxides
- (2010) Markku Ahotupa et al. ANNALS OF MEDICINE
- Exenatide suppresses postprandial elevations in lipids and lipoproteins in individuals with impaired glucose tolerance and recent onset type 2 diabetes mellitus
- (2010) Eric A. Schwartz et al. ATHEROSCLEROSIS
- One-year treatment with exenatide vs. Insulin Glargine: Effects on postprandial glycemia, lipid profiles, and oxidative stress
- (2010) Mathijs C. Bunck et al. ATHEROSCLEROSIS
- Inhibition of Monocyte Adhesion to Endothelial Cells and Attenuation of Atherosclerotic Lesion by a Glucagon-like Peptide-1 Receptor Agonist, Exendin-4
- (2010) M. Arakawa et al. DIABETES
- Estimated glomerular filtration rate and albuminuria are independent predictors of cardiovascular events and death in type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study
- (2010) P. L. Drury et al. DIABETOLOGIA
- Glucagon-like peptide-1 (GLP-1) inhibits advanced glycation end product (AGE)-induced up-regulation of VCAM-1 mRNA levels in endothelial cells by suppressing AGE receptor (RAGE) expression
- (2009) Yuji Ishibashi et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Increase in Plasma Endotoxin Concentrations and the Expression of Toll-Like Receptors and Suppressor of Cytokine Signaling-3 in Mononuclear Cells After a High-Fat, High-Carbohydrate Meal: Implications for insulin resistance
- (2009) H. Ghanim et al. DIABETES CARE
- The glucagon-like peptide 1 receptor is essential for postprandial lipoprotein synthesis and secretion in hamsters and mice
- (2009) J. Hsieh et al. DIABETOLOGIA
- Intensive glucose control and macrovascular outcomes in type 2 diabetes
- (2009) F. M. Turnbull et al. DIABETOLOGIA
- Lowering Blood Pressure Reduces Renal Events in Type 2 Diabetes
- (2009) B. E. de Galan et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- After the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study: Implications for Fenofibrate
- (2008) Frank M. Sacks AMERICAN JOURNAL OF CARDIOLOGY
- Alimentary lipemia enhances procoagulatory effects of inflammation in patients with a history of acute myocardial infarction complicated by ventricular fibrillation
- (2007) Thorsten Kälsch et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More